Liver Disease

Liver Disease

Guilt by Association: The Link Between NASH, MAFLD, Diabetes, and Obesity

As obesity rates continue to climb so does metabolic associated fatty liver disease (MAFLD), often at an alarming rate. Endocrine News talks to Theodore C. Friedman, MD, PhD, and Magda Shaheen, MD, PhD, about research they presented at ENDO 2023 on fatty liver disease’s link to diabetes, what impact new medications could have, and how...

Liver Disease

Endocrine Targets: Treating Steatotic Liver Disease

Endocrine dysfunction plays a prominent role in the development of steatotic liver disease and was featured prominently with a multi-session program at ENDO 2023. Endocrinologists will be on the front lines to help patients stave off this disorder that will no longer be known as “fatty liver disease,” which is projected to become the leading...

Non-Alcoholic Fatty Liver Disease: The Silent Epidemic and Emerging Research for Detection and Treatment

Along with the public health challenges of obesity and diabetes, endocrinologists are now becoming keenly aware of the prevalence of another ominous threat: non-alcoholic steatohepatitis (NASH). Endocrine Society members Abhinav Seth, MD, PhD, and Roberto Calle, MD, both with Regeneron, give Endocrine News an exclusive primer on this disorder, as well as a future path...

Women with Irregular Periods May Be at Risk for Liver Disease

Women with long or irregular periods are known to have a higher risk of type 2 diabetes and heart disease, but researchers found these women may also be at risk for nonalcoholic fatty liver disease (NAFLD), according to a new study published in The Journal of Clinical Endocrinology and Metabolism. About 24% of U.S. adults have...

Liver Disease

Endocrine news on twitter